Trials / Completed
CompletedNCT02126670
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Promius Pharma, LLC · Industry
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACT01 | |
| DRUG | Comp01 | |
| DRUG | Comp02 | |
| DRUG | Comp03 | |
| DRUG | Comp04 |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-04-30
- Last updated
- 2016-02-22
- Results posted
- 2016-02-22
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02126670. Inclusion in this directory is not an endorsement.